 | • レポートコード：QYR9ST04211 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、多発性硬化症薬の世界市場について調査・分析し、多発性硬化症薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口薬、非経口薬）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多発性硬化症薬市場動向 ・主要企業別マーケットシェア ・多発性硬化症薬の種類別市場規模2014-2019 （経口薬、非経口薬） ・多発性硬化症薬の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・多発性硬化症薬の北米市場：主要企業・種類別/用途別市場規模 ・多発性硬化症薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・多発性硬化症薬の中国市場：主要企業・種類別/用途別市場規模 ・多発性硬化症薬の日本国内市場：主要企業・種類別/用途別市場規模 ・多発性硬化症薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・多発性硬化症薬のインド市場：主要企業・種類別/用途別市場規模 ・多発性硬化症薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GlaxoSmithKline、Novartis、Merck、Sanofi、Pfizer、Bayer、Teva Pharmaceutical、Abbvie、Biogen Idec、AB Science、Opexa） ・多発性硬化症薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells. This damage blocks messages between brain and the body and leads to the symptoms of MS. Some of the major symptoms of MS include thinking and memory problems, visual disturbances, problem in coordination and balancing of the body and muscle weakness. MS affects women more than men. The disease often occurs between age group of 20-40. MS is mainly divided into four types. They are relapsing-remitting MS, progressive-relapsing MS, secondary-progressive MS and primary-progressive MS. Relapsing-remitting MS is the most common form of the disease. It accounts about 85% of the total MS cases. Secondary-progressive is associated with the initial period of relapsing-remitting disease. Approximately, 50% of people suffering with relapsing remitting MS would develop this form of the disease. Progressive-relapsing MS is rare and about 5% of the total MS cases. Primary-progressive MS accounts 10% of the total MS cases.
In terms of geographic, North America dominates the global MS drugs market. The U.S. represents the largest market for MS drugs followed by Canada in North America. In Europe, France, Germany, Italy, Spain and the U.K. holds major share of MS drugs market. However, Asia is expected to show high growth rates in the next five years in global MS drugs market. This is due to many companies constructing their manufacturing and research facilities in the region. Developing regions have advantage over the developed regions due to low wages, availability of a large talent pool, less stringent environment and health and safety regulations. Japan, China and India are expected to be the fastest growing MS drugs markets in Asia.
In 2018, the global Multiple Sclerosis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Multiple Sclerosis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis Drugs development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline
Novartis
Merck
Sanofi
Pfizer
Bayer
Teva Pharmaceutical
Abbvie
Biogen Idec
AB Science
Opexa
Market segment by Type, the product can be split into
Oral Drugs
Parenteral Drugs
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Multiple Sclerosis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Multiple Sclerosis Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Multiple Sclerosis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Sclerosis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Drugs
1.4.3 Parenteral Drugs
1.5 Market by Application
1.5.1 Global Multiple Sclerosis Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Multiple Sclerosis Drugs Market Size
2.2 Multiple Sclerosis Drugs Growth Trends by Regions
2.2.1 Multiple Sclerosis Drugs Market Size by Regions (2014-2025)
2.2.2 Multiple Sclerosis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Multiple Sclerosis Drugs Market Size by Manufacturers
3.1.1 Global Multiple Sclerosis Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Multiple Sclerosis Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multiple Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Sclerosis Drugs Key Players Head office and Area Served
3.3 Key Players Multiple Sclerosis Drugs Product/Solution/Service
3.4 Date of Enter into Multiple Sclerosis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Multiple Sclerosis Drugs Market Size by Type (2014-2019)
4.2 Global Multiple Sclerosis Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Multiple Sclerosis Drugs Market Size (2014-2019)
5.2 Multiple Sclerosis Drugs Key Players in United States
5.3 United States Multiple Sclerosis Drugs Market Size by Type
5.4 United States Multiple Sclerosis Drugs Market Size by Application
6 Europe
6.1 Europe Multiple Sclerosis Drugs Market Size (2014-2019)
6.2 Multiple Sclerosis Drugs Key Players in Europe
6.3 Europe Multiple Sclerosis Drugs Market Size by Type
6.4 Europe Multiple Sclerosis Drugs Market Size by Application
7 China
7.1 China Multiple Sclerosis Drugs Market Size (2014-2019)
7.2 Multiple Sclerosis Drugs Key Players in China
7.3 China Multiple Sclerosis Drugs Market Size by Type
7.4 China Multiple Sclerosis Drugs Market Size by Application
8 Japan
8.1 Japan Multiple Sclerosis Drugs Market Size (2014-2019)
8.2 Multiple Sclerosis Drugs Key Players in Japan
8.3 Japan Multiple Sclerosis Drugs Market Size by Type
8.4 Japan Multiple Sclerosis Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Multiple Sclerosis Drugs Market Size (2014-2019)
9.2 Multiple Sclerosis Drugs Key Players in Southeast Asia
9.3 Southeast Asia Multiple Sclerosis Drugs Market Size by Type
9.4 Southeast Asia Multiple Sclerosis Drugs Market Size by Application
10 India
10.1 India Multiple Sclerosis Drugs Market Size (2014-2019)
10.2 Multiple Sclerosis Drugs Key Players in India
10.3 India Multiple Sclerosis Drugs Market Size by Type
10.4 India Multiple Sclerosis Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Multiple Sclerosis Drugs Market Size (2014-2019)
11.2 Multiple Sclerosis Drugs Key Players in Central & South America
11.3 Central & South America Multiple Sclerosis Drugs Market Size by Type
11.4 Central & South America Multiple Sclerosis Drugs Market Size by Application
12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Sclerosis Drugs Introduction
12.1.4 GlaxoSmithKline Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Sclerosis Drugs Introduction
12.2.4 Novartis Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Sclerosis Drugs Introduction
12.3.4 Merck Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Sclerosis Drugs Introduction
12.4.4 Sanofi Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Sclerosis Drugs Introduction
12.5.4 Pfizer Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Multiple Sclerosis Drugs Introduction
12.6.4 Bayer Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Multiple Sclerosis Drugs Introduction
12.7.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development
12.8 Abbvie
12.8.1 Abbvie Company Details
12.8.2 Company Description and Business Overview
12.8.3 Multiple Sclerosis Drugs Introduction
12.8.4 Abbvie Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.8.5 Abbvie Recent Development
12.9 Biogen Idec
12.9.1 Biogen Idec Company Details
12.9.2 Company Description and Business Overview
12.9.3 Multiple Sclerosis Drugs Introduction
12.9.4 Biogen Idec Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.9.5 Biogen Idec Recent Development
12.10 AB Science
12.10.1 AB Science Company Details
12.10.2 Company Description and Business Overview
12.10.3 Multiple Sclerosis Drugs Introduction
12.10.4 AB Science Revenue in Multiple Sclerosis Drugs Business (2014-2019)
12.10.5 AB Science Recent Development
12.11 Opexa
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Multiple Sclerosis Drugs Key Market Segments
Table Key Players Multiple Sclerosis Drugs Covered
Table Global Multiple Sclerosis Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Drugs Market Size Market Share by Type 2014-2025
Figure Oral Drugs Figures
Table Key Players of Oral Drugs
Figure Parenteral Drugs Figures
Table Key Players of Parenteral Drugs
Table Global Multiple Sclerosis Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Multiple Sclerosis Drugs Report Years Considered
Table Global Multiple Sclerosis Drugs Market Size 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multiple Sclerosis Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Multiple Sclerosis Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Multiple Sclerosis Drugs Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Drugs Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Multiple Sclerosis Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Multiple Sclerosis Drugs Market Share by Manufacturers (2014-2019)
Figure Global Multiple Sclerosis Drugs Market Share by Manufacturers in 2018
Table Global Multiple Sclerosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multiple Sclerosis Drugs Product/Solution/Service
Table Date of Enter into Multiple Sclerosis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Multiple Sclerosis Drugs Market Size Share by Type (2014-2019)
Figure Global Multiple Sclerosis Drugs Market Size Market Share by Type (2014-2019)
Table Global Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Multiple Sclerosis Drugs Market Size Share by Application (2014-2019)
Figure Global Multiple Sclerosis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Multiple Sclerosis Drugs Revenue Market Share by Application in 2018
Figure United States Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table United States Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table United States Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure Europe Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table Europe Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table Europe Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure China Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table China Multiple Sclerosis Drugs Market Size by Type (2014-20189) (Million US$)
Table China Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table China Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table China Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure Japan Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table Japan Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table Japan Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table Southeast Asia Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table Southeast Asia Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure India Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table India Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table India Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table India Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table India Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Figure Central & South America Multiple Sclerosis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multiple Sclerosis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multiple Sclerosis Drugs Market Share (2018-2019)
Table Central & South America Multiple Sclerosis Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Drugs Market Share by Type (2014-2019)
Table Central & South America Multiple Sclerosis Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Drugs Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Multiple Sclerosis Drugs Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Bayer Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Abbvie Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure Biogen Idec Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table Biogen Idec Recent Development
Table AB Science Company Details
Table AB Science Revenue in Multiple Sclerosis Drugs Business (2014-2019)(Million US$)
Figure AB Science Revenue Growth Rate in Multiple Sclerosis Drugs Business (2014-2019)
Table AB Science Recent Development
Table Opexa Company Details
Table Global Multiple Sclerosis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Multiple Sclerosis Drugs Market Size Share by Regions (2019-2025)
Figure Global Multiple Sclerosis Drugs Market Size Share by Regions in 2025
Figure United States Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multiple Sclerosis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Multiple Sclerosis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Drugs Market Size by Product (2019-2025)
Figure Global Multiple Sclerosis Drugs Market Size by Product in 2025
Table Global Multiple Sclerosis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Drugs Market Size by Application (2019-2025)
Figure Global Multiple Sclerosis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
多発性硬化症の世界市場：市場規模・現状・予測 Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentia…- 多発性硬化症治療の世界市場：市場規模・現状・予測 Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…
- 多発性硬化症向け幹細胞療法の世界市場：市場規模・現状・予測 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- てんかん薬の世界市場：市場規模・現状・予測 Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…
- OTC外用薬の世界市場：市場規模・現状・予測 Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…